Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
59.1%
% of PJP's 22 holdings also in FTXH
26.0%
% of FTXH's 51 holdings also in PJP
Overlap by Weight
Sector Drift (PJP minus FTXH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PJP |
Weight in FTXH |
Overlap | |
---|---|---|---|---|
ABBVIE INC | 5.9% | 7.3% | 5.9% | |
PFIZER INC | 5.7% | 7.4% | 5.7% | |
JOHNSON & JOHNSON | 5.7% | 6.9% | 5.7% | |
MERCK & CO. INC. | 5.6% | 7.0% | 5.6% | |
ELI LILLY & CO | 5.9% | 3.7% | 3.7% |
Position Highlights (Non-Overlapping Exposures)
PJP Overweight Relative to FTXH
GERON CORP | 6.1% | |
ABBOTT LABORATORIES | 5.5% | |
SUPERNUS PHARMACEUTICALS INC | 4.4% | |
BIOSANTE PHARMACEUTICALS INC | 4.3% | |
CORCEPT THERAPEUTICS INC | 3.9% | |
LIGAND PHARMACEUTICALS-CL B | 3.5% | |
PACIRA PHARMACEUTICALS INC | 3.5% | |
INNOVIVA, INC. | 3.4% | |
PRESTIGE BRANDS HOLDINGS INC | 3.0% | |
AMPHASTAR PHARMACEUTICALS INC | 3.0% |
PJP Underweight Relative to FTXH
BRISTOL-MYERS SQUIBB CO | -7.3% | |
CARDINAL HEALTH INC | -3.6% | |
VERTEX PHARMACEUTICALS INC | -3.5% | |
VIATRIS, INC. | -3.4% | |
ZOETIS INC | -3.1% | |
ORGANON & CO. | -2.5% | |
CHARLES RIVER LABORATORIES | -2.3% | |
PFIZER INC | -1.7% | |
MEDPACE HOLDINGS, INC. | -1.5% | |
ABBVIE INC | -1.4% |